SCHEMBL9716650

SCHEMBL9716650

CCCC(=O)N(CC(=O)O)c1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.74
ALDH1A1 P00352 1/20 0.52
GLA P06280 1/20 0.52
TSHR P16473 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.51
LTB4R2 Q9NPC1 5/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
MLYCD O95822 1/20 0.48
NPC1 O15118 1/20 0.46
JAK2 O60674 1/20 0.46
RAB9A P51151 1/20 0.46
PAX8 Q06710 1/20 0.46
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9716804 0.90 TP53 (0.60) TP53ALDH1A1GLATSHRSMN1; SMN2
SCHEMBL9666922 0.88 TP53 (0.58) TP53ALDH1A1GLATSHRSMN1; SMN2
SCHEMBL4740482 0.87 TP53 (0.57) TP53ALDH1A1GLATSHRSMN1; SMN2
SCHEMBL4743986 0.87 TP53 (0.57) TP53ALDH1A1GLATSHRSMN1; SMN2
SCHEMBL9664195 0.87 TP53 (0.57) TP53ALDH1A1GLATSHRSMN1; SMN2
SCHEMBL9666989 0.87 TP53 (0.57) TP53ALDH1A1GLATSHRSMN1; SMN2
SCHEMBL9664702 0.87 TP53 (0.57) TP53ALDH1A1GLATSHRSMN1; SMN2
SCHEMBL4740473 0.87 TP53 (0.57) TP53ALDH1A1GLATSHRSMN1; SMN2
SCHEMBL4062526 0.87 TP53 (0.57) TP53ALDH1A1GLATSHRSMN1; SMN2
SCHEMBL4744095 0.87 TP53 (0.57) TP53ALDH1A1GLATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250000948-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID ADOCIA (FR) 2025-01-02 US disclosed
EP-4433093-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2024-09-25 EP disclosed
EP-4299057-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2024-01-03 EP disclosed
WO-2023084118-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID ADOCIA (FR) 2023-05-19 WO disclosed
EP-4180060-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID Adocia (FR) 2023-05-17 EP disclosed
EP-0178911-B1 COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC SANKYO COMPANY LIMITED (JP) 1992-01-22 EP disclosed
US-4757066-A Reduces renal toxicity SANKYO COMPANY LIMITED (JP) 1988-07-12 US disclosed
EP-0178911-A2 Composition containing a penem or carbapenem antibiotic SANKYO COMPANY LIMITED (JP) 1986-04-23 EP disclosed
US-4442090-A ACYLATED AMINO ACID KYOTO YAKUHIN KOGYO KABUSHIKI KAISHA (JP) 1984-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250000948-A1 SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID NPPA, BCAT1, ANPEP TP53 1737/4885ALDH1A1 4701/4885GLA 2586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.